Cybin Inc. Stock OTC Markets
Stocks
CLXP.F
CA23256X1006
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
OTC Markets
2021-09-01
|
5-day change | 1st Jan Change | ||
| 2.630 CAD | -6.07% |
|
+17.41% | +76.51% |
| Market Cap | 1.3B 920M 809M 765M 694M 88.3B 1.31B 9.16B 3.54B 45.06B 3.45B 3.38B 145B | P/E 2027 * |
-4.82x | P/E 2028 * | -5.84x |
|---|---|---|---|---|---|
| Enterprise Value | 820M 579M 509M 482M 437M 55.59B 825M 5.77B 2.23B 28.37B 2.17B 2.13B 91.16B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | 66.1x |
| Free-Float |
85.98% | Yield 2027 * |
-
| Yield 2028 * | - |
Last Transcript: Cybin Inc.
| 1 day | -6.07% |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Glavine
COO | Chief Operating Officer | 37 | 2016-10-12 |
Michael Halstead
CEO | Chief Executive Officer | 53 | 2026-08-02 |
Eric So
CEO | Chief Executive Officer | 51 | 2025-09-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric So
CHM | Chairman | 51 | 2020-11-04 |
Paul Glavine
BRD | Director/Board Member | 37 | 2016-10-12 |
Eric Hoskins
BRD | Director/Board Member | 65 | 2020-11-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.07% | +17.41% | - | - | 921M | |
| -0.37% | +1.12% | +57.21% | +84.56% | 72.26B | |
| -0.07% | -2.70% | +37.74% | +86.90% | 60.24B | |
| +0.75% | +6.06% | +36.71% | +19.87% | 27.73B | |
| -0.14% | -2.75% | -14.13% | +356.79% | 25.73B | |
| +0.57% | +1.10% | +1.02% | -2.89% | 24.75B | |
| +1.10% | +1.86% | +25.07% | -8.51% | 20.74B | |
| -1.70% | -2.12% | +150.24% | +323.16% | 15.06B | |
| +0.36% | +2.01% | +49.51% | +160.70% | 14.41B | |
| -2.53% | -1.39% | -6.38% | +469.36% | 14.23B | |
| Average | -0.81% | -0.13% | +37.44% | +165.55% | 30.57B | |
| Weighted average by Cap. | -0.14% | -1.05% | +38.13% | +126.08% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 11.07M 7.81M 6.87M 6.5M 5.89M 750M 11.13M 77.79M 30.04M 383M 29.33M 28.7M 1.23B |
| Net income | -261M -185M -162M -153M -139M -17.71B -263M -1.84B -710M -9.04B -693M -678M -29.04B | -262M -185M -162M -154M -139M -17.73B -263M -1.84B -710M -9.05B -693M -678M -29.07B |
| Net Debt | -483M -341M -300M -283M -257M -32.7B -485M -3.39B -1.31B -16.69B -1.28B -1.25B -53.63B | -571M -403M -355M -335M -304M -38.69B -574M -4.01B -1.55B -19.74B -1.51B -1.48B -63.45B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HELP Stock
- CLXP.F Stock
Select your edition
All financial news and data tailored to specific country editions
